Lilly says it's confident in weight-loss pill supply ahead of U.S. approval Jan 12 (Reuters) - Eli Lilly LLY.N said on Monday it is confident about the supplies of its weight-loss pill orforglipron ahead of its anticipated U.S. approval in the coming months.
"We intend to launch in many, many countries around the world, as quickly as possible," Daniel Skovronsky, Lilly head of research and development, told Reuters in an interview on the sidelines of a major industry conference that kicked off Monday in San Francisco.
(Reporting by Maggie Fick and Michael Erman in San Fransisco; Writing by Mariam Sunny in Bengaluru; Editing by Maju Samuel)
((Mariam.ESunny@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments